TOP STORIES

• REGULATORY R&D Tax Credit Refit Taking Shape; Open Innovation Scheme Likely to Cover Research Commissioned to Big Firms
  December 10, 2018

• REGULATORY JPMA Official Renews Call for Use of “Specified Clinical Research” Data in Application Dossiers
  December 7, 2018

• REGULATORY Chuikyo Agrees on 3 ICER Thresholds for “Tiered” CEA Price Adjustment Model; Industry Hearing Slated by Year-End
  December 6, 2018

• BUSINESS Shareholders Give Blessing to £46 Billion Shire Pact as Weber Touts US Foothold
  December 6, 2018

• BUSINESS Takeda Shareholders OK £46 Billion Shire Takeover
  December 5, 2018

• ORGANIZATION 9 EFPIA Companies Reviewed Headcount Planning after Drug Pricing Overhaul: Survey
  December 5, 2018

• BUSINESS Takeda Family Member Comes Forward for Final Appeal to Veto Shire Deal, but Admits Uphill Battle
  December 4, 2018

• BUSINESS With Current R&D Model Reaching Its Limit, Industry Going Digital to Boost Efficiency: Astellas Chairman
  December 3, 2018

• BUSINESS JT to Return Rights to Gilead’s 6 HIV Agents in 2019, Get 63.1 Billion Yen
  November 30, 2018

• BUSINESS Dissident Shareholder Group Hails Ex-Takeda Chief’s Opposition to Shire Deal
  November 29, 2018

• REGULATORY AMED Study Group Drafting Japan’s 1st Guidelines for Development of Recombinant Virus Vaccines
  November 29, 2018

• TRENDS Generic Industry at Crossroads: Companies Face Pressing Need to Boost Profitability ahead of FY2020
  November 28, 2018

• BUSINESS Keytruda Continues to Close in on Opdivo in July-September Global Sales
  November 27, 2018

• REGULATORY MHLW Proposes Introduction of Administrative Fines for Improperly Earned Revenues
  November 27, 2018

• BUSINESS Dissident Takeda Shareholders Making Final Pitch to Thwart Shire Buyout
  November 26, 2018

• REGULATORY MHLW Eyes Drastic Change to Cost Effective Analysis Flow, Enhanced Discussions Upfront
  November 22, 2018

• REGULATORY MHLW Proposes Quarterly Product Selections, Price Tweaks for CEA Scheme: Chuikyo
  November 22, 2018

• BUSINESS Pfizer’s ALK Inhibitor Lorbrena, Shire’s HAE Drug Now Available in Japan
  November 21, 2018

• BUSINESS Mitsubishi Tanabe Cuts FY2020 Targets in 5-Year Biz Plan on Flagging Royalty, Development Delay
  November 21, 2018

• BUSINESS 3 Japan Generic Majors Log 6% Growth in Combined April-September Sales despite Price Revision
  November 20, 2018

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »